Dr. Charles Cuerrier, Dr. Andrew E. Pellingand, Dr. Daniel Modulevsky founded Spiderwort secured US $13.2M Series A led by Horizons Ventures with participation of K5 Global, BoxOne Ventures, Break Off Capital and others. Patrick Zhang from Horizons Ventures joined Spiderwort board of directors.
Spiderwort is a Canada-based biotechnology company that develops and commercializes novel cellulose biomaterials for the treatment of soft tissue replacement.